Characterisation of ambulatory COPD patients with long-term oxygen therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027874

Enrollment

Registered

2022-01-26

Start date

2022-01-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J44.8

Interventions

Group 1: Patients with: - Diagnosis of COPD (including pulmonary function FEV1/FVC <70% or LLN < -1.645 and FEV1 <80%). - existing LTOT - Able to give informed consent, signed privacy and patient inf

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Diagnosis of COPD (including pulmonary function FEV1/FVC <70% or LLN < -1.645 and FEV1 <80%). - LTOT - Able to give consent, signed data protection and patient* informed consent.

Exclusion criteria

Exclusion criteria: - Acute exacerbation of COPD in the last 8 weeks, defined as acute worsening of respiratory symptoms lasting for at least 2 days respiratory symptoms with the need for intensification of therapy. - Patient age <18 years - Deafness - Incapable of giving consent, without substitute legal guardianship

Design outcomes

Primary

Measure	Time frame
Explorative prospective assessment and characterisation of outpatients with COPD and respiratory insufficiency type 1 with and without long-term oxygen therapy	—

Secondary

Measure	Time frame
Quality of care and health-related quality of life of ambulatory COPD patients with long-term oxygen therapy	—

Countries

Germany

Contacts

Public ContactFriederike Magnet

Klinken der Stadt Köln gGmbh Lungenklinik MerheimUniversität Witten/Herdecke

magnetf@kliniken-koeln.de0221-89073250

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026